Table of Contents Table of Contents
Previous Page  204 / 220 Next Page
Information
Show Menu
Previous Page 204 / 220 Next Page
Page Background

We also found no association between self-reported

medical diagnosis of GERD and the odds of overall HNSCC

(Table II). Most ORs were again in an inverse direction,

but laryngeal cases had a slightly greater odds of having

been diagnosed with GERD compared to controls.

In analyses of combined laryngeal and pharyngeal

cases, among those who were neither heavy smokers nor

heavy drinkers we detected no association between

GERD and the development of laryngopharyngeal cancer

for either self-reported history of GERD symptoms or

medical diagnosis of GERD (Table III). Likewise, no

associations between GERD and laryngopharyngeal

cancer were detected among subjects who were heavy

smokers and/or heavy drinkers (Table III).

TABLE I.

Subject Characteristics.

Variable

Controls

(N

5

1,378)

All Cases

(N

5

1,340)

P

Value*

Hypopharynx

Cases

(N

5

67)

Larynx

Cases

(N

5

473)

NOS

Cases

(N

5

247)

Oral Cavity

Cases

(N

5

192)

Oropharynx

Cases

(N

5

361)

Age (years)

<

0.0001

20–49

156 (11%)

254 (19%)

9 (13%)

64 (14%)

58 (23%)

37 (19%)

86 (24%)

50–54

161 (12%)

210 (16%)

16 (24%)

50 (11%)

40 (16%)

20 (10%)

84 (23%)

55–59

207 (15%)

222 (17%)

13 (19%)

71 (15%)

38 (15%)

31 (16%)

69 (19%)

60–64

205 (15%)

229 (17%)

10 (15%)

95 (20%)

41 (17%)

30 (16%)

53 (15%)

65–69

247 (18%)

178 (13%)

7 (10%)

81 (17%)

30 (12%)

25 (13%)

35 (10%)

70–74

231 (17%)

152 (11%)

3 (4%)

73 (15%)

22 (9%)

29 (15%)

25 (7%)

75–80

171 (12%)

95 (7%)

9 (13%)

39 (8%)

18 (7%)

20 (10%)

9 (2%)

Sex

0.0001

Male

960 (70%) 1,021 (76%)

56 (84%)

372 (79%) 171 (69%) 123 (64%) 299 (83%)

Female

418 (30%)

319 (24%)

11 (16%)

101 (21%)

76 (31%)

69 (36%)

62 (17%)

Race

<

0.0001

White

1,114 (81%)

989 (74%)

39 (58%)

345 (73%) 188 (76%) 140 (73%) 277 (77%)

Black

264 (19%)

351 (26%)

28 (42%)

128 (27%)

59 (24%)

52 (27%)

84 (23%)

Years Smoked Cigarettes

<

0.0001

Never smoker

525 (38%)

173 (13%)

5 (8%)

19 (4%)

57 (23%)

21 (11%)

71 (20%)

1–19

293 (21%)

118 (9%)

3 (5%)

26 (6%)

30 (12%)

12 (6%)

47 (13%)

20–39

334 (24%)

499 (38%)

26 (41%)

180 (38%)

68 (28%)

79 (42%) 146 (41%)

40–49

142 (10%)

344 (26%)

19 (30%)

150 (32%)

65 (27%)

47 (25%)

63 (18%)

50

1

78 (6%)

194 (15%)

10 (16%)

97 (21%)

25 (10%)

31 (16%)

31 (9%)

Lifetime Alcohol Consumption (mL)

<

0.0001

Never had alcohol

296 (22%)

125 (10%)

1 (2%)

45 (10%)

27 (12%)

23 (13%)

29 (9%)

<

11,232

161 (12%)

58 (5%)

3 (5%)

21 (5%)

15 (7%)

6 (3%)

13 (4%)

11,232-

<

204,469

406 (31%)

234 (19%)

3 (5%)

77 (18%)

46 (20%)

23 (13%)

85 (25%)

204,469-

<

927,946

321 (24%)

319 (26%)

12 (20%)

122 (28%)

53 (23%)

42 (23%)

90 (27%)

927,946

1

144 (11%)

497 (40%)

40 (68%)

169 (39%)

85 (38%)

86 (48%) 117 (35%)

Body Mass Index

<

0.0001

Underweight (

<

18.5)

30 (2%)

100 (7%)

14 (21%)

25 (5%)

20 (8%)

20 (10%)

21 (6%)

Normal (18.5-

<

25.0)

405 (29%)

482 (36%)

26 (39%)

161 (34%)

93 (38%)

88 (46%) 114 (32%)

Overweight (25.0-

<

30.0)

551 (40%)

434 (32%)

19 (28%)

159 (34%)

71 (29%)

55 (29%) 130 (36%)

Obese (30.0

1

)

392 (28%)

324 (24%)

8 (12%)

128 (27%)

63 (26%)

29 (15%)

96 (27%)

Education

<

0.0001

Less than high school

217 (16%)

458 (34%)

32 (48%)

197 (42%)

64 (26%)

67 (35%)

98 (27%)

High school/vocational/tech

490 (36%)

492 (37%)

18 (27%)

173 (37%)

89 (36%)

73 (38%) 139 (39%)

At least some college

671 (49%)

390 (29%)

17 (25%)

103 (22%)

94 (38%)

52 (27%) 124 (34%)

Ever had frequent heartburn

0.8

No

1,007 (76%)

989 (77%)

43 (69%)

344 (75%) 194 (81%) 145 (81%) 263 (74%)

Yes

315 (24%)

303 (23%)

19 (31%)

112 (25%)

47 (20%)

34 (19%)

91 (26%)

Ever diagnosed with GERD

0.1

No

994 (77%) 1,008 (79%)

53 (84%)

329 (73%) 200 (84%) 147 (83%) 279 (80%)

Yes

303 (23%)

266 (21%)

10 (16%)

120 (27%)

37 (16%)

31 (17%)

68 (20%)

*Chi-square comparisons between controls and overall cases.

NOS

5

Not otherwise specified, GERD

5

gastroesophageal reflux disease

Laryngoscope 126: May 2016

Busch et al.: GERD and Head and Neck Cancer

184